Zobrazeno 1 - 10
of 1 572
pro vyhledávání: '"Fadel, S."'
Autor:
McClymont, E., Atkinson, A., Albert, A., Av-Gay, G., Andrade, J., Barrett, J., Bogler, T., Boucoiran, I., Castillo, E., D'Souza, R., El-Chaâr, D., Fadel, S., Fell, D.B., Korchinski, I., Kuret, V., Ogilvie, G., Poliquin, V., Sadarangani, M., Scott, H., Snelgrove, J.W., Tunde-Byass, M., Money, D.
Publikováno v:
In Vaccine 22 November 2023 41(48):7183-7191
Publikováno v:
In Results in Chemistry January 2023 5
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
PD-L1 promotes oncolytic virus infection via a metabolic shift that inhibits the type I IFN pathway.
Autor:
Hodgins JJ; Cancer Therapeutics Program, Ottawa Hospital Research Institute , Ottawa, Canada.; Department of Biochemistry, Microbiology, and Immunology, University of Ottawa, Ottawa, Canada.; Center for Infection, Immunity, and Inflammation, University of Ottawa , Ottawa, Canada., Abou-Hamad J; Cancer Therapeutics Program, Ottawa Hospital Research Institute , Ottawa, Canada.; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Canada., O'Dwyer CE; Cancer Therapeutics Program, Ottawa Hospital Research Institute , Ottawa, Canada.; Department of Biochemistry, Microbiology, and Immunology, University of Ottawa, Ottawa, Canada.; Center for Infection, Immunity, and Inflammation, University of Ottawa , Ottawa, Canada., Hagerman A; Cancer Therapeutics Program, Ottawa Hospital Research Institute , Ottawa, Canada.; Center for Infection, Immunity, and Inflammation, University of Ottawa , Ottawa, Canada., Yakubovich E; Cancer Therapeutics Program, Ottawa Hospital Research Institute , Ottawa, Canada.; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Canada., Tanese de Souza C; Cancer Therapeutics Program, Ottawa Hospital Research Institute , Ottawa, Canada., Marotel M; Cancer Therapeutics Program, Ottawa Hospital Research Institute , Ottawa, Canada.; Center for Infection, Immunity, and Inflammation, University of Ottawa , Ottawa, Canada., Buchler A; Department of Chemistry and Biomolecular Sciences, University of Ottawa, Ottawa, Canada.; University of Ottawa Heart Institute , Ottawa, Canada., Fadel S; The Ottawa Hospital , Ottawa, Canada.; Department of Pathology and Laboratory Medicine, The Ottawa Hospital, Ottawa, Canada., Park MM; Cancer Therapeutics Program, Ottawa Hospital Research Institute , Ottawa, Canada.; Center for Infection, Immunity, and Inflammation, University of Ottawa , Ottawa, Canada., Fong-McMaster C; Department of Biochemistry, Microbiology, and Immunology, University of Ottawa, Ottawa, Canada.; Ottawa Institute for Systems Biology , Ottawa, Canada., Crupi MF; Cancer Therapeutics Program, Ottawa Hospital Research Institute , Ottawa, Canada., Makinson OJ; Cancer Therapeutics Program, Ottawa Hospital Research Institute , Ottawa, Canada.; Department of Biochemistry, Microbiology, and Immunology, University of Ottawa, Ottawa, Canada.; Center for Infection, Immunity, and Inflammation, University of Ottawa , Ottawa, Canada., Kurdieh R; Cancer Therapeutics Program, Ottawa Hospital Research Institute , Ottawa, Canada., Rezaei R; Cancer Therapeutics Program, Ottawa Hospital Research Institute , Ottawa, Canada.; Department of Biochemistry, Microbiology, and Immunology, University of Ottawa, Ottawa, Canada.; Center for Infection, Immunity, and Inflammation, University of Ottawa , Ottawa, Canada., Dhillon HS; Cancer Therapeutics Program, Ottawa Hospital Research Institute , Ottawa, Canada.; Department of Biochemistry, Microbiology, and Immunology, University of Ottawa, Ottawa, Canada.; Center for Infection, Immunity, and Inflammation, University of Ottawa , Ottawa, Canada., Ilkow CS; Cancer Therapeutics Program, Ottawa Hospital Research Institute , Ottawa, Canada.; Department of Biochemistry, Microbiology, and Immunology, University of Ottawa, Ottawa, Canada.; Center for Infection, Immunity, and Inflammation, University of Ottawa , Ottawa, Canada., Bell JC; Cancer Therapeutics Program, Ottawa Hospital Research Institute , Ottawa, Canada.; Department of Biochemistry, Microbiology, and Immunology, University of Ottawa, Ottawa, Canada., Harper ME; Department of Biochemistry, Microbiology, and Immunology, University of Ottawa, Ottawa, Canada.; Center for Infection, Immunity, and Inflammation, University of Ottawa , Ottawa, Canada.; Ottawa Institute for Systems Biology , Ottawa, Canada., Rotstein BH; Department of Biochemistry, Microbiology, and Immunology, University of Ottawa, Ottawa, Canada.; Department of Chemistry and Biomolecular Sciences, University of Ottawa, Ottawa, Canada.; University of Ottawa Heart Institute , Ottawa, Canada., Auer RC; Cancer Therapeutics Program, Ottawa Hospital Research Institute , Ottawa, Canada.; Department of Biochemistry, Microbiology, and Immunology, University of Ottawa, Ottawa, Canada., Vanderhyden BC; Cancer Therapeutics Program, Ottawa Hospital Research Institute , Ottawa, Canada.; Center for Infection, Immunity, and Inflammation, University of Ottawa , Ottawa, Canada.; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Canada., Sabourin LA; Cancer Therapeutics Program, Ottawa Hospital Research Institute , Ottawa, Canada.; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Canada., Bourgeois-Daigneault MC; Department of Microbiology, Infectious Diseases, and Immunology, University of Montreal, Montreal, Canada.; Centre Hospitalier de l'Université de Montréal Research Centre, Cancer and Immunopathology axes , Montreal, Canada., Cook DP; Cancer Therapeutics Program, Ottawa Hospital Research Institute , Ottawa, Canada.; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Canada., Ardolino M; Cancer Therapeutics Program, Ottawa Hospital Research Institute , Ottawa, Canada.; Department of Biochemistry, Microbiology, and Immunology, University of Ottawa, Ottawa, Canada.; Center for Infection, Immunity, and Inflammation, University of Ottawa , Ottawa, Canada.
Publikováno v:
The Journal of experimental medicine [J Exp Med] 2024 Jul 01; Vol. 221 (7). Date of Electronic Publication: 2024 Jun 13.
Publikováno v:
مجلة كلية التربية للبنات, Vol 31, Iss 4 (2020)
The present research is descriptive and analytical by nature; it practically presents the method of implementing the standard pattern in an unconventional way using the bias-cut line. The study aims at investigating the variables of bias-cut and thei
Externí odkaz:
https://doaj.org/article/d298468b39f348978bed4c186be02bc9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Murphy CS; Center for Molecular Medicine, MaineHealth Institute for Research, Scarborough, ME, USA.; University of Maine, University of Maine Graduate School of Biomedical Science and Engineering, Orono, ME, USA., DeMambro VE; Center for Molecular Medicine, MaineHealth Institute for Research, Scarborough, ME, USA.; University of Maine, University of Maine Graduate School of Biomedical Science and Engineering, Orono, ME, USA., Fadel S; Center for Molecular Medicine, MaineHealth Institute for Research, Scarborough, ME, USA.; University of New England, Biddeford, ME, USA., Fairfield H; Center for Molecular Medicine, MaineHealth Institute for Research, Scarborough, ME, USA.; University of Maine, University of Maine Graduate School of Biomedical Science and Engineering, Orono, ME, USA.; Tufts University School of Medicine, Boston MA, USA., Garter CA; Center for Molecular Medicine, MaineHealth Institute for Research, Scarborough, ME, USA.; University of Maine, University of Maine Graduate School of Biomedical Science and Engineering, Orono, ME, USA., Rodriguez P; University of Vermont, Burlington, VT, USA., Qiang YW; Center for Molecular Medicine, MaineHealth Institute for Research, Scarborough, ME, USA., Vary CPH; Center for Molecular Medicine, MaineHealth Institute for Research, Scarborough, ME, USA.; University of Maine, University of Maine Graduate School of Biomedical Science and Engineering, Orono, ME, USA.; Tufts University School of Medicine, Boston MA, USA., Reagan MR; Center for Molecular Medicine, MaineHealth Institute for Research, Scarborough, ME, USA.; University of Maine, University of Maine Graduate School of Biomedical Science and Engineering, Orono, ME, USA.; Tufts University School of Medicine, Boston MA, USA.
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2024 Mar 14. Date of Electronic Publication: 2024 Mar 14.
Autor:
Fadel S. Hamid, Omayma A. Elkady, A. R. S. Essa, A. El-Nikhaily, Ayman Elsayed, Ashraf K. Eessaa
Publikováno v:
Crystals, Vol 11, Iss 9, p 1081 (2021)
Bi-modal particles are used as reinforcements for Cu-matrix. Nano TiC and/or Al2O3 were mechanically mixed with Cu particles for 24 h. The Cu-TiC/Al2O3 composites were successfully produced using spark plasma sintering (SPS). To investigate the effec
Externí odkaz:
https://doaj.org/article/1f0a6d61c56a4a1f9c9d92d9e2b61094
Publikováno v:
Iraqi Journal of Agricultural Sciences. 2021, Vol. 52 Issue 6, p1482-1488. 7p.
Autor:
null Elhefny, M., null Odah, M., null AlHazazi, O., null Khalil, D. M., null Fadel, S., null Ghazawy, E., null Abdelrahim, M., null Abdelbagi, O., null Ewis, A.
Publikováno v:
Malaysian Journal of Microbiology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7afbf29b855ff92c510b0c80be8d3e9c
https://doi.org/10.21161/mjm.220088
https://doi.org/10.21161/mjm.220088